Degrofarm SRL
Degrofarm reported total assets of €1.47m at the end of the 2026 financial year (annual accounts filed with the NBB on 10 Jul 2026).
The score of Degrofarm shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2026
Change 2023 → 2026: Equity -37 % Total assets -4 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Degrofarm's annual accounts
Filed annual accounts
- Year ended 31 Mar 2026filed on 10 Jul 2026
- Year ended 31 Mar 2025filed on 21 Aug 2025
- Year ended 31 Mar 2024filed on 30 Aug 2024
- Year ended 31 Mar 2023filed on 30 Oct 2023
- Year ended 31 Mar 2022filed on 03 Nov 2022
Degrofarm's financial analysis
- Solvency10.2%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Degrofarm
Degrofarm's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0733.978.016
- VAT number
- BE0733978016
- Peppol
- Registered · 0208:0733978016 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 12 Sep 2019
- Registered office
- 9850 Deinze
- Latest accounts
- 2026 · filed on 10 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Degrofarm (SRL) has been based in Deinze since 2019, active in: retail sale of pharmaceutical products. For 2026, it reports a net profit of 50,680 € and equity of 150,500 €; its revenue is not published. Its solvency stands at 10.2%, below the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Degrofarm
Companies in the same business, of comparable size and area, outside its group.
- PG Pharmaceuticals Business and other management consultancy activities Opwijk · balance sheet €1.86m
- Pharmacie Brasseur L. Business and other management consultancy activities Wavre · balance sheet €1.05m
- Pavobur Retail sale of pharmaceutical products Vosselaar · balance sheet 943,141 €
- Pharmanext Retail sale of pharmaceutical products Ixelles · balance sheet €2.33m
- Omnicare Farma Dam Retail sale of pharmaceutical products Lokeren · balance sheet €1.25m
- Apotheek Spriet Retail sale of pharmaceutical products Berlare · balance sheet 772,384 €
- Farmacie Henri Retail sale of pharmaceutical products Edegem · balance sheet 635,645 €
- APO2370 Retail sale of pharmaceutical products Arendonk · balance sheet €3.86m
Frequently asked questions about Degrofarm
What is the revenue of Degrofarm?
Degrofarm files its accounts in a format where revenue is optional: it is not published for 2026.
What is the VAT number of Degrofarm?
In Belgium, the VAT number is the company number prefixed with BE: BE0733978016 for Degrofarm, if the company is VAT-registered. Its company number (CBE) is 0733.978.016.
Where is the registered office of Degrofarm?
According to the CBE register, the registered office of Degrofarm is in 9850 Deinze.
What is the equity of Degrofarm?
At the close of the 2026 financial year, the equity of Degrofarm amounts to 150,500 €, a solvency of 10.2% of total assets.
Who manages Degrofarm?
The register lists 1 active mandates at Degrofarm. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Degrofarm
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →